- Home
- BBUC vs SUPN Comparison
BBUC vs SUPN Comparison
Compare BBUC & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBUC
- SUPN
- Stock Information
- Founded
- BBUC 2022
- SUPN 2005
- Country
- BBUC United States
- SUPN United States
- Employees
- BBUC N/A
- SUPN N/A
- Industry
- BBUC
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- BBUC
- SUPN Health Care
- Exchange
- BBUC Nasdaq
- SUPN Nasdaq
- Market Cap
- BBUC 1.7B
- SUPN 1.7B
- IPO Year
- BBUC N/A
- SUPN 2012
- Fundamental
- Price
- BBUC $23.94
- SUPN $30.76
- Analyst Decision
- BBUC
- SUPN Hold
- Analyst Count
- BBUC 0
- SUPN 2
- Target Price
- BBUC N/A
- SUPN $36.00
- AVG Volume (30 Days)
- BBUC 95.4K
- SUPN 647.0K
- Earning Date
- BBUC 01-01-0001
- SUPN 05-07-2025
- Dividend Yield
- BBUC 1.04%
- SUPN N/A
- EPS Growth
- BBUC N/A
- SUPN 6500.00
- EPS
- BBUC N/A
- SUPN 1.32
- Revenue
- BBUC $8,208,000,000.00
- SUPN $661,817,000.00
- Revenue This Year
- BBUC N/A
- SUPN N/A
- Revenue Next Year
- BBUC N/A
- SUPN $9.32
- P/E Ratio
- BBUC N/A
- SUPN $23.30
- Revenue Growth
- BBUC 6.83
- SUPN 8.94
- 52 Week Low
- BBUC $18.21
- SUPN $25.53
- 52 Week High
- BBUC $28.45
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- BBUC 43.77
- SUPN 40.39
- Support Level
- BBUC $23.29
- SUPN $29.77
- Resistance Level
- BBUC $24.51
- SUPN $34.26
- Average True Range (ATR)
- BBUC 1.47
- SUPN 1.51
- MACD
- BBUC -0.13
- SUPN -0.04
- Stochastic Oscillator
- BBUC 40.35
- SUPN 22.05
About BBUC Brookfield Business Corporation Exchangeable Subordinate Voting Shares
Brookfield Business Corp is a company established as a vehicle that owns and operates certain services and industrial operations on a world-wide basis and an alternative vehicle for investors who prefer investing in its operations through a corporate structure. Its goal is to generate returns through long-term capital appreciation with a modest distribution yield.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.